As of 2025-03-19, the EV/EBITDA ratio of Novocure Ltd (NVCR) is -16.52. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Novocure's latest enterprise value is 2,619.74 mil USD. Novocure's TTM EBITDA according to its financial statements is -158.58 mil USD. Dividing these 2 quantities gives us the above Novocure EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.4x - 19.6x | 14.8x |
| Forward P/E multiples | 21.2x - 26.0x | 23.8x |
| Fair Price | (35.03) - (32.81) | (32.24) |
| Upside | -280.9% - -269.5% | -266.6% |
| Date | EV/EBITDA |
| 2025-03-07 | -17.09 |
| 2025-03-06 | -16.45 |
| 2025-03-05 | -16.37 |
| 2025-03-04 | -15.71 |
| 2025-03-03 | -15.86 |
| 2025-02-28 | -16.32 |
| 2025-02-27 | -16.43 |
| 2025-02-26 | -18.32 |
| 2025-02-25 | -17.66 |
| 2025-02-24 | -17.82 |
| 2025-02-21 | -18.41 |
| 2025-02-20 | -18.11 |
| 2025-02-19 | -18.22 |
| 2025-02-18 | -18.38 |
| 2025-02-14 | -18.68 |
| 2025-02-13 | -18.15 |
| 2025-02-12 | -17.91 |
| 2025-02-11 | -17.80 |
| 2025-02-10 | -18.11 |
| 2025-02-07 | -18.52 |
| 2025-02-06 | -18.99 |
| 2025-02-05 | -19.86 |
| 2025-02-04 | -19.51 |
| 2025-02-03 | -19.56 |
| 2025-01-31 | -20.10 |
| 2025-01-30 | -20.78 |
| 2025-01-29 | -20.79 |
| 2025-01-28 | -20.82 |
| 2025-01-27 | -20.69 |
| 2025-01-24 | -21.35 |
| 2025-01-23 | -21.83 |
| 2025-01-22 | -21.69 |
| 2025-01-21 | -21.79 |
| 2025-01-17 | -21.24 |
| 2025-01-16 | -21.14 |
| 2025-01-15 | -21.37 |
| 2025-01-14 | -21.28 |
| 2025-01-13 | -22.08 |
| 2025-01-10 | -22.13 |
| 2025-01-08 | -23.14 |
| 2025-01-07 | -23.21 |
| 2025-01-06 | -23.66 |
| 2025-01-03 | -24.03 |
| 2025-01-02 | -23.89 |
| 2024-12-31 | -23.76 |
| 2024-12-30 | -23.95 |
| 2024-12-27 | -24.38 |
| 2024-12-26 | -25.21 |
| 2024-12-24 | -24.57 |
| 2024-12-23 | -24.24 |